Evidence map›Paper›PMID 20026200›Full record

ArticleInternational journal of pharmaceutics2010

A skin permeability model of insulin in the presence of chemical penetration enhancer.

K M Yerramsetty, B J Neely, S V Madihally, K A M Gasem

Abstract readValidation Study
In one paragraph

Article in International journal of pharmaceutics, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

K M Yerramsetty423 Engineering North, School of Chemical Engineering, Oklahoma State University, Stillwater, OK 74078, United States.
B J Neely
S V Madihally
K A M Gasem

Funding

Design of Chemical Penetration Enhancers for Transdermal Drug DeliveryR21EB005749 · NIBIB · OKLAHOMA STATE UNIVERSITY STILLWATER · PI GASEM, K A.M. · 2006 to 2007
$396k
NIBIB NIH HHS 1R21EB005749NIBIB NIH HHS R21 EB005749
6 · The paper itself

Abstract

Enhancing transdermal delivery of insulin using chemical penetration enhancers (CPEs) has several advantages over other non-traditional methods; however, lack of suitable predictive models, make experimentation the only alternative for discovering new CPEs. To address this limitation, a quantitative structure-property relationship (QSPR) model was developed, for predicting insulin permeation in the presence of CPEs. A virtual design algorithm that incorporates QSPR models for predicting CPE properties was used to identify 48 potential CPEs. Permeation experiments using Franz diffusion cells and resistance experiments were performed to quantify the effect of CPEs on insulin permeability and skin structure, respectively. Of the 48 CPEs, 35 were used for training and 13 were used for validation. In addition, 12 CPEs reported in literature were also included in the validation set. Differential evolution (DE) was coupled with artificial neural networks (ANNs) to develop the non-linear QSPR models. The six-descriptor model had a 16% absolute average deviation (%AAD) in the training set and 4 misclassifications in the validation set. Five of the six descriptors were found to be statistically significant after sensitivity analyses. The results suggest, molecules with low dipoles that are capable of forming intermolecular bonds with skin lipid bi-layers show promise as effective insulin-specific CPEs.

Indexed as

Skin AbsorptionAdministration, CutaneousAlgorithmsAnimalsChemistry, PharmaceuticalDiffusionExcipientsHypoglycemic AgentsInsulinModels, BiologicalNeural Networks, ComputerNonlinear DynamicsPermeabilityQuantitative Structure-Activity RelationshipSkinSwineExcipientsHypoglycemic AgentsInsulin

Identifiers

PMID20026200
PMCPMC2846626

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.